Alnylam Pharmaceuticals, Inc. (ALNY)

400.59 -0.10 (-0.02%) USD  |  NASDAQ  |  Dec 26, 16:00
400.36 -0.23 (-0.06%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Glaukos Corp. Upgrade
BridgeBio Pharma, Inc. Upgrade